http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5500409-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 1993-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300e498364bc7daba3492d5cf3a7eb5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba76db623d8fbabadcc57a4a121437e5 |
| publicationDate | 1996-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5500409-A |
| titleOfInvention | Method for inhibiting collagen synthesis by keloid fibroblasts |
| abstract | A composition for the treatment of skin fibrotic and other cirrhotic diseases comprising an endothelial cell growth factor, either alone or in combination with heparin or a heparin-like compound is provided. Methods for the treatment of skin fibrotic and other cirrhotic diseases and for inhibition of collagen synthesis by skin fibroblasts using an endothelial cell growth factor either alone or in combination with heparin or a heparin-like compound are also provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877185-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007137429-A1 |
| priorityDate | 1990-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.